physostigmine has been researched along with Bipolar Disorder in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (85.71) | 18.7374 |
1990's | 1 (3.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (7.14) | 24.3611 |
2020's | 1 (3.57) | 2.80 |
Authors | Studies |
---|---|
Akudjedu, TN; Ambati, S; Cannon, DM; Dauvermann, MR; Farrell, J; Frodl, T; Gill, M; Hallahan, B; Kilmartin, L; Martyn, FM; McDonald, C; McLoughlin, J; McPhilemy, G; Meaney, J; Morris, D; Nabulsi, L; Najt, P | 1 |
Baroke, E; Kielstein, JT; Kühn-Velten, WN; Schmidt, JJ; Strunk, AK; Wiesner, O | 1 |
Geyer, MA; Milienne-Petiot, M; van Enkhuizen, J; Young, JW | 1 |
Davis, J; DeMet, E; Dysken, M; Halaris, A; Harrow, M; Ostrow, D | 1 |
Khouzam, HR; Kissmeyer, PM | 1 |
Davis, JM | 3 |
Davis, J; Gershon, S; Janowsky, D; Shopsin, B | 2 |
Belmaker, RH; Ebstein, RP; Oppenheim, G | 1 |
Barchas, JD; Berger, PA; Davis, KL; Hollister, LE | 1 |
Berger, PA; Davis, KL | 1 |
Berger, PA; Davis, KL; Defraites, E; Hollister, LE | 1 |
Telford, R; Worrall, EP | 1 |
Gabriel, E; Karobath, M; Küfferle, B; Schuster, P; Strobl, G | 1 |
Anderson, MH; Lynch, H | 1 |
Gillin, JC; Huey, L; Janowsky, DS; Rausch, J; Risch, SC; Ziegler, MG | 1 |
Huey, LY; Janowsky, DS; Rausch, JL; Risch, SC | 1 |
Lerer, B | 1 |
Davis, JM; el-Yousef, MK; Hubbard, B; Janowsky, DS; Sekerke, HJ | 1 |
Carroll, BJ; Frazer, A; Mendels, J; Schless, A | 1 |
Davis, JM; Janowsky, D | 1 |
Carroll, BJ | 1 |
Hunger, J; Modestin, J; Schwartz, RB | 1 |
Davis, JM; el-Yousef, K; Janowsky, DS; Sekerke, HJ | 1 |
Davis, JM; el-Yousef, MK; Janowsky, DS; Sekerke, HJ | 1 |
1 review(s) available for physostigmine and Bipolar Disorder
Article | Year |
---|---|
Alternative therapies for bipolar disorder.
Topics: Ascorbic Acid; Bipolar Disorder; Bupropion; Carbamazepine; Choline; Clonazepam; Clonidine; Clorgyline; Demeclocycline; Fenfluramine; Humans; Methylene Blue; Phosphatidylcholines; Physostigmine; Propiophenones; Propranolol; Spironolactone; Thyroxine; Tryptophan; Valproic Acid | 1985 |
7 trial(s) available for physostigmine and Bipolar Disorder
Article | Year |
---|---|
Rebound phenomena in manic patients following physostigmine. Preliminary observations.
Topics: Bipolar Disorder; Clinical Trials as Topic; Humans; Male; Models, Neurological; Neurotransmitter Agents; Physostigmine | 1975 |
Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
Topics: Acetylcholine; Adult; Aged; Bipolar Disorder; Brain; Choline; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Physostigmine; Psychotic Disorders; Receptors, Cholinergic; Schizophrenia | 1978 |
Physostigmine in mania.
Topics: Affect; Bipolar Disorder; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Infusions, Parenteral; Male; Nausea; Physostigmine; Psychiatric Status Rating Scales; Vomiting | 1978 |
Cholinergic reversal of manic symptoms.
Topics: Bipolar Disorder; Clinical Trials as Topic; Female; Humans; Parasympathomimetics; Physostigmine; Psychiatric Status Rating Scales | 1972 |
Proceedings: Rebound phenomenon in manic patients following physostigmine: towards an understanding of aminergic mechanisms underlying affective disorders.
Topics: Amines; Bipolar Disorder; Humans; Male; Physostigmine; Placebos | 1974 |
[Depressive effects of physostigmine].
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Emotions; Female; Humans; Male; Middle Aged; Neostigmine; Physostigmine; Placebos; Scopolamine | 1973 |
Parasympathetic suppression of manic symptoms by physostigmine.
Topics: Acetylcholine; Adult; Affect; Bipolar Disorder; Brain Chemistry; Dopamine; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Humans; Injections, Intravenous; Male; Neostigmine; Norepinephrine; Parasympathetic Nervous System; Physostigmine; Placebos; Remission, Spontaneous; Schizophrenia | 1973 |
20 other study(ies) available for physostigmine and Bipolar Disorder
Article | Year |
---|---|
Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex.
Topics: Acetylcholinesterase; Bipolar Disorder; Case-Control Studies; Cholinergic Agents; Emotions; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Physostigmine; Synaptic Transmission | 2022 |
Saving two lives with one dialysis treatment.
Topics: Bipolar Disorder; Cholinesterase Inhibitors; Diphenhydramine; Drug Overdose; Female; Humans; Hypnotics and Sedatives; Physostigmine; Renal Dialysis; Suicide, Attempted; Young Adult | 2015 |
Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features.
Topics: Acetylcholine; Animals; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Cholinesterase Inhibitors; Depression; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Exploratory Behavior; Female; Hindlimb Suspension; Lithium Compounds; Male; Mice; Mice, Inbred C57BL; Physostigmine; Piperazines; Prepulse Inhibition; Sensory Gating; Swimming | 2015 |
State dependence of noradrenergic activity in a rapidly cycling bipolar patient.
Topics: Adolescent; Adult; Bipolar Disorder; Chlorpromazine; Circadian Rhythm; Electroconvulsive Therapy; Feedback; Female; Glycols; Humans; Lithium; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Physostigmine; Receptors, Adrenergic; Receptors, Muscarinic | 1984 |
Physostigmine temporarily and dramatically reversing acute mania.
Topics: Antiparkinson Agents; Benztropine; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Overdose; Humans; Infusions, Intravenous; Male; Middle Aged; Parasympathomimetics; Physostigmine; Veterans | 1996 |
Critique of single amine theories: evidence of a cholinergic influence in the major mental illnesses.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Disorder; Child; Cognition Disorders; Dopamine; Emotions; Humans; Methylphenidate; Middle Aged; Monoamine Oxidase; Neostigmine; Norepinephrine; Parasympathetic Nervous System; Phenothiazines; Physostigmine; Schizophrenia; Sympathetic Nervous System | 1975 |
Effect of lithium on the physostigmine-induced behavioral syndrome and plasma cyclic GMP.
Topics: Adult; Bipolar Disorder; Cyclic GMP; Depression; Female; Guanylate Cyclase; Humans; Lithium; Male; Physostigmine | 1979 |
Adrenergic-cholinergic imbalance in affective disorders.
Topics: Animals; Bipolar Disorder; Choline; Depression; Humans; Physostigmine; Receptors, Adrenergic; Receptors, Cholinergic | 1976 |
Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation.
Topics: Biogenic Amines; Bipolar Disorder; Humans; Huntington Disease; Movement Disorders; Parasympathetic Nervous System; Physostigmine; Psychotic Disorders; Research Design; Schizophrenia; Tranquilizing Agents | 1975 |
Cognitive functions in manic-depressives: effects of lithium and physostigmine.
Topics: Bipolar Disorder; Cognition; Humans; Injections, Subcutaneous; Lithium; Physostigmine; Psychological Tests | 1978 |
Reversal by physostigmine of clozapine-induced delirium.
Topics: Adult; Bipolar Disorder; Clozapine; Delirium; Dibenzazepines; Female; Humans; Male; Physostigmine | 1977 |
Atropine coma therapy in psychiatry: clinical observations over a 20-year period and a review of the literature.
Topics: Adolescent; Adult; Aged; Antidotes; Anxiety; Atropine; Bipolar Disorder; Coma; Electronarcosis; Humans; Indiana; Middle Aged; Neurotic Disorders; Physostigmine; Psychiatric Nursing; Psychotherapy; Psychotic Disorders; Retrospective Studies; Schizophrenia | 1975 |
Physostigmine-induced epinephrine release in patients with affective disorder.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Diagnosis, Differential; Epinephrine; Humans; Infusions, Parenteral; Middle Aged; Norepinephrine; Physostigmine; Psychotic Disorders | 1986 |
A kinetic analysis and replication of decreased platelet serotonin uptake in depressed patients.
Topics: Bipolar Disorder; Blood Platelets; Depressive Disorder; Humans; Kinetics; Mental Disorders; Mood Disorders; Physostigmine; Serotonin | 1986 |
Cholinergic reversal of manic symptoms.
Topics: Adult; Bipolar Disorder; Humans; Male; Middle Aged; Physostigmine | 1973 |
Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Depression; Dihydroergotoxine; Drug Interactions; Electroconvulsive Therapy; Gonadal Steroid Hormones; Guanethidine; Haloperidol; Humans; Lithium; Mental Disorders; Physostigmine; Psychotropic Drugs; Schizophrenia; Thiothixene; Thioxanthenes; Vitamins | 1974 |
Proceedings: Cholinergic and adrenergic balance in mania and schizophrenia.
Topics: Bipolar Disorder; Humans; Parasympathetic Nervous System; Physostigmine; Schizophrenia; Sympathetic Nervous System | 1974 |
Proceedings: Role of acetylcholine and dopamine in manic behavior.
Topics: Acetylcholine; Animals; Bipolar Disorder; Dopamine; Humans; Mice; Physostigmine; Stereotyped Behavior | 1974 |
A two factor theory of schizophrenia.
Topics: Acetylcholine; Amphetamine; Animals; Bipolar Disorder; Brain; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Humans; Methyl Ethers; Methylphenidate; Physostigmine; Schizophrenia; Stereoisomerism; Stereotyped Behavior | 1974 |
Antagonistic effects of physostigmine and methylphenidate in man.
Topics: Affective Symptoms; Behavior; Bipolar Disorder; Humans; Inhibition, Psychological; Methylphenidate; Neostigmine; Physostigmine; Schizophrenia; Scopolamine | 1973 |